ACET · NASDAQ · Biotechnology

Adicet Bio (ACET)

Develops off-the-shelf gamma delta CAR-T cell therapies for autoimmune disease and cancer.

$9.28
After-hours close+0.19 (+2.09%)
At close$9.09(+1.79%)
  1. Adicet Bio (ACET) Upgraded to Buy: Here's Why

    Zacks Investment Research